Related Experiment Video
Updated: Sep 10, 2025

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
81.0K
Novel and optimized diagnostics for pediatric TB in endemic countries: NOD-pedFEND study protocol
Rinn Song1, Else Margreet Bijker2,3, Grace Kisitu4
1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. rinn.song@paediatrics.ox.ac.uk.
BMC Pediatrics
|August 24, 2025
Summary
Accurate diagnosis of pediatric tuberculosis (TB) is crucial. This large study in young children aims to improve diagnostic tests for TB, especially using non-sputum samples, to aid treatment and public health efforts.
Area of Science:
- Global Health
- Infectious Diseases
- Pediatric Medicine
Background:
- Pediatric tuberculosis (TB) poses a significant global health challenge.
- Accurate diagnosis is a major barrier to effective treatment in children.
- Current diagnostic studies are limited by small sample sizes and few confirmed cases.
Purpose of the Study:
- To evaluate existing and novel diagnostic assays for pediatric tuberculosis.
- To enroll one of the largest cohorts of children at high risk for TB.
- To improve diagnostic capabilities, particularly in children under five years of age.
Main Methods:
- Prospective observational cohort study in Uganda and Peru.
- Enrollment of children under five with suspected TB symptoms.
- Comprehensive baseline workup including microbiological tests, chest X-ray, and sample collection for investigational tests.
Main Results:
- This section is not applicable for the protocol description.
- This section is not applicable for the protocol description.
- This section is not applicable for the protocol description.
Conclusions:
- This large cohort study will significantly contribute to evaluating new pediatric TB diagnostics.
- The established biorepository will facilitate assessment of novel tests.
- Findings will aid in identifying and treating children with tuberculosis more effectively.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis V
238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
Pulmonary Tuberculosis II
345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis III
442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
442
Pneumonia III: Complications and Assessment
435
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
435

